Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
6.82
↓ 90% below average
Average (9y)
66.19
Historical baseline
Range
High:566.76
Low:0.61
CAGR
-12.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 6.82 | +396.8% |
| 2023 | 1.37 | +124.3% |
| 2022 | 0.61 | -77.5% |
| 2021 | 2.72 | -70.3% |
| 2020 | 9.17 | +214.9% |
| 2019 | 2.91 | -92.2% |
| 2018 | 37.22 | -93.4% |
| 2017 | 566.76 | +4332.0% |
| 2016 | 12.79 | -40.7% |
| 2015 | 21.57 | - |